Dr. Mohanty will oversee clinical care and evaluation of patients with liver and GI diseases.
“Dr. Mohanty is an exceptional leader in gastroenterology and liver diseases, and we are proud to welcome him to Newark Beth Israel Medical Center,” Darrell Terry, CEO and president of Newark Beth Israel Medical Center and Children’s Hospital of New Jersey, said in a statement. “His extensive experience and clinical expertise in gastrointestinal and liver diseases as well as his research in racial disparities in liver disease make him uniquely qualified for this role.”
Dr. Mohanty has worked in GI care for over 20 years and has specialized in liver transplants and liver disease.
He has also served as the chief of the division of gastroenterology and hepatobiliary disease and director of the Center for Liver Disease at NewYork-Presbyterian-Brooklyn Methodist Hospital in New York City and as an assistant professor of medicine at the University of Chicago.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.